NR1D1 and triple-A syndrome: For instance, Gasdermin D (GSDMD),[50]NR1D1,[51] and TFEB[52] derived from VSMCs, have been identified as key regulators of AAA development by modulating VSMC apoptosis, mitochondria metabolism, and phenotype switching.